Redeye: Stille (Q3 update) - Prolonged headwind but valuation remains undemanding
Redeye provides an updated view of Stille following the Q3 2025 report. Amid prolonged supply chain constraints, FX headwinds, and the phase-out of non-strategic products, we have updated our near-term estimates and fair value range.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/